Global Partnership AJ Vaccines operates from Copenhagen with a global mission and collaborates with regional partners and prestigious institutions, presenting opportunities to offer joint development programs, contract manufacturing, or diagnostic tool collaborations across Europe and beyond.

Expansion Potential The company has invested in production facilities and recruited aggressively to secure a position in the vaccine market, signaling openness to scale manufacturing partnerships, supply chain enhancements, and equipment or process optimization services.

WHO Prequalification Recent WHO prequalification of a new inactivated polio vaccine indicates readiness to meet global demand; sales opportunities exist in international procurement, tender support, and technology transfer for additional vaccine lines.

Public Health Focus A history of COVID-19 vaccine development and adjuvanted IPV programs demonstrates alignment with urgent health challenges, creating openings for strategic collaborations on vaccine candidates, diagnostics, and therapeutic solutions.

Digital & Data Enablement Tech stack includes Power BI, SAP, SQL Server, and cloud capabilities, suggesting a fit for analytics-driven partnerships, supply chain optimization, ERP integrations, and digital transformation services to support manufacturing and quality systems.